Ixoreal Biomed highlights an exploratory placebo-controlled study of SRI-81 Shatavari, alone and combined with KSM-66 Ashwagandha, published in the International Journal of Women’s Health.
|Articles|January 21, 2011
Aker Biomarine Receives Nutrition Business Journal Award
The company received an award for growth by a mid-sized company.
Advertisement
The company reported 300% growth in 2010 with sales exceeding $20 million through the first three quarters.
Superba krill oil provides a phospholipid delivery form of the omega-3 fatty acids EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), and astaxanthin.
The company has conducted in vitro, in vivo, and human clinical research to demonstrate the safety and efficacy of its krill oil product. Superba krill oil is also certified sustainable by the
Advertisement
Related to this article
Clinical research moves beyond compliance, focusing on smarter trial design, risk-based quality, and “evidence engineering” to deliver decisive, decision-ready results.
The company says the innovation, built on its CoreNhanced BioJourney platform, is designed for beverage and gummy formats.
AuraFen, BILVORA, and IMBE debut at SupplySide Global 2026, and the company will also highlight its CaFi digestive health ingredient.
Horphag Research's Sébastien Bornet breaks down the clinical science behind Robuvit, exploring how the caffeine-free French oak extract supports mitochondrial energy, mood stability, and stress resilience.
Todd Harrison, co-chair of the FDA practice group at Venable LLP, explains how California’s AB 2779 changes date-labeling requirements for supplements, why stability testing matters, and how companies can navigate evolving state rules while advocating for federal uniformity.
FDA's final NDI guidance sets identity and safety expectations. See what AHPA and CRN say remains unresolved and what it means for suppliers.
The company plans to present Organicaps capsules in size 0, 25 years of UC-II, and liquid-filled capsule technology.
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
Navigating Supplement Ingredients and Claims Regulations in Europe, the US, and Canada
2
CoreFX Launches CreaSHLD-IN Shielded Creatine at SupplySide Global 2026
3
FDA Finalizes NDI Guidance on Identity and Safety Information, Leaving Some Industry Concerns Open
4
Lonza Capsugel to Feature Organicaps, UC-II, and Capsule Delivery Technologies at SupplySide Global 2026
5